Sun Pharma, Tata Steel, Yes Bank and UPL gained the most on both indices, while Asian Paints, Infosys, and GAIL were the top losers.
Sun Pharma, Adani Ports, and Aurobindo Pharma were the top gainers, while Dr Reddyâs Labs, ONGC and BPCL lost the most.
TCS, HCL Tech, Tech Mahindra and ITC were the top gainers, while Sun Pharma, IndusInd Bank, and Hindalco lost the most.
Benchmark indices slipped more than 1.5 percent in three consecutive sessions, and lost around 7 percent in three weeks from all-time record closing highs on January 29, 2018.
Fortis Healthcare, Bhushan Steel, Amtek Auto, Kaya and JSW Energy gained 1-5 percent.
Union Bank, Allahabad Bank, Bank of Baroda, Syndicate Bank, Bank of India, Indian Bank and Bank of Baroda shares declined 4.5-7.5 percent.
PSU Bank index slipped 2 percent as total exposure announced by PSU banks so far has been more than Rs 8,500 crore to PNB fraud case.
Both benchmark indices closed flat for the week, after losing nearly 6 percent in previous two weeks.
Punjab National Bank lost another 2 percent on top of 21 percent fall in previous two consecutive sessions. Gitanjali Gems tanked 19 percent on top of 20 percent correction in previous session.
PNB shares lost another 13 percent after detecting transaction fraud of Rs 11,333 crore in a Mumbai branch.
PNB fell over 11 percent after management gave clarification over transaction fraud worth Rs 11,333 crore.
Voltamp Transformers, NRB Bearings, Kolte-Patil, DLF, IOL Chemicals, Ester, Dilip Buildcon, NMDC, Britannia Industries, Ashok Leyland and Minda Industries gained 1-4 percent whereas JK Tyre and Motherson Sumi lost 2-4 percent post earnings.
FIIs pulled out Rs 814 crore from Indian equity markets on Monday while DIIs invested Rs 1,342 crore in the previous trading session.
Prescient Wealth Management sold 7,98,319 shares of Finolex Industries.
BNP Paribas Arbitrage bought 42,75,000 shares of Fortis Healthcare.
IndusInd Bank Ltd Client A/C sold 1,10,00,000 shares of Jaypee Infratech.
Jubilant Consumer sold 27,36,000 shares of Jubilant Life at Rs 914 on the NSE.
United States Food and Drug Administration (USFDA) has issues Form 483 with 3 observations to the company#39;s Halol unit.
The Trump administration announced a new policy that makes very tough the procedure of issuing H-1B visas to those to be employed at one or more third-party worksites
Here are a few top buzzing midcap stocks picked by CNBC-TV18#39;s analysts in trade today â Jaypee Infra, Fortis Healthcare, and Punjab National Bank.
The company announced a launch of fully configurable, high-throughput backhaul modem running on Xilinx all programmable Zynq UltraScale MPSoC devices.
The company#39;s board in its meeting held on February 21 has approved to sell its mobility division and rail traction drives business Siemens AG or its subsidiary.
Around 59.8 lakh shares of the company were traded in six blocks on the NSE at the price of Rs 914-940.05 per share.
The company has received Letter of Award (LoA) from lrcon lnternational (Government of India Undertaking) for a new EPC project in the state of Karnataka.
Merck has posted 42 percent increase in its Q3FY18 net profit at Rs 27 crore and revenue was up 22 percent at Rs 304 crore.
The market breadth was in favour of the advances with 1246 stocks advancing while 358 decllined and 402 remained unchanged. On the other hand, in the BSE, 1527 stocks advanced and 546 declined and 87 remained unchanged.
There were pending buy orders of 98,206 shares, with no sellers available.
The company has entered into MoU with UP state government for Rs 73.44 crore for expansion of its paper unit III from installed capacity of 70 MT to 100 MT.